Showing 2481-2490 of 10490 results for "".
Part 7, 1726 nm lasers: When a patient doesn’t improve: Doctors discuss “pearls” of wisdom
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24345/Chapter 7 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about when a patient doesn’t improve: Doctors discuss “pearls” of wisdom.FDA Approval for Delgocitinib
https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/Robert Spurr, EVP, North America for LEO Pharma, discusses the importance of an FDA-approved option for treating moderate-to-severe chronic hand eczema in adults.Vtama Approved for AD in Adults and Children
https://practicaldermatology.com/series/dermwire-tv/vtama-approved-ad-adults-and-children/30079/In this week's DermwireTV, the FDA approves Vtama (tapinarof cream 0.1%) for atopic dermatitis in adults and children; the FDA approves Nemluvio (nemolizumab) for moderate-to-severe AD; and the president of Nuance Medical discusses the acquisition of scar treatment brand, Biocorneum.DermWireTV: Olumiant Approved for AA; Radiesse + Launch; Derms as Influencers; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-olumiant-approved-for-aa-radiesse-launch-derms-as-influencers-vcs/20107/Olumiant (baricitinib) from Eli Lilly and Company is approved to treat adult patients with severe alopecia areata. Dermatologists rank as top influencers of consumers’ decisions to have cosmetic procedures, according to results of the American Society for Dermatologic Surgery (ASDS) Consumer SurveyAdvocating for Dermatology: The Benefits of Being Involved
https://practicaldermatology.com/topics/practice-management/advocating-for-dermatology-the-benefits-of-being-involved/20087/Neal Bhatia, MD shares his appreciation for being able to have served as the American Academy of Dermatology’s Vice President for the last year. He shares his thoughts on the importance of getting involved and advocating for the specialty.Embracing AI
https://practicaldermatology.com/topics/practice-management/embracing-ai/20080/Artificial intelligence is something dermatologists should be embracing as augmented intelligence. Anthony Rossi, MD says this intelligence will allow us to better diagnose, assess, and treat patients with everything from acne to melanoma.Five ways to market for the “next normal”
https://practicaldermatology.com/topics/practice-management/five-ways-to-market-for-the-next-normal/20015/You’ve heard it time and time again. The “new normal.” We have been living and working within this new environment for almost two years. In this Ekwa Marketing video, we ask, “What is the next normal?” We isolate five ways to market for tomorrow’s increasingly digitally savvy, curious, socially awarCOVID and Biologics
https://practicaldermatology.com/series/dermatology-education-foundation/covid-and-biologics/19981/Is it safe to continue biologic therapies amid the COVID-19 pandemic? Are vaccines safe for these patients? Leon Kircik, MD talks about why he tells his patients to continue to use their medications and encourages them to get the COVID vaccine.Dermoscopy Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermoscopy-pearls/19985/Steven Q. Wang discusses some of the challenges of managing patients with melanoma, the importance of early diagnosis without performing too many biopsies, and the pitfalls of specific lesions, including featureless, small, and collision lesions.DermWireTV: Impact of COVID-19 on Dermatology
https://practicaldermatology.com/topics/practice-management/dermwiretv-impact-of-covid-19-on-dermatology/19878/As COVID-19 infections surge across the US, a vaccine has been approved. What's it mean for dermatology patients? And how is the pandemic impacting dermatology practices? Updates from the International Psoriasis Council; Mark Nestor, MD; Amy Taub, MD; Terrence Keaney, MD; and Melissa Kanchanapoomi L